An Efficacy and Safety Study of Somatuline Depot (Lanreotide) Injection to Treat Carcinoid Syndrome

Clinical trial NCT00774930 · COMPLETED

Trial details

NCT number: NCT00774930
Sponsor: Ipsen
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Carcinoid Syndrome

Start date: 2009-05-01
Primary completion: 2013-05-01
Enrollment: 115

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.